IP Library Granted Patent US 7,056,704
Granted Patent B2
US 7,056,704 · App. 10/832,432 · Granted Jun 6, 2006

RNA interference mediating small RNA molecules

Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,056,704
App. No.
10/832,432
Granted
Jun 6, 2006
Kind
B2
Abstract

Double-stranded RNA (dsRNA) induces sequence-specific post-transcriptional gene silencing in many organisms by a process known as RNA interference (RNAi). Using a Drosophila in vitro system, we demonstrate that 19–23 nt short RNA fragments are the sequence-specific mediators of RNAi. The short interfering RNAs (siRNAs) are generated by an RNase III-like processing reaction from long dsRNA. Chemically synthesized siRNA duplexes with overhanging 3′ ends mediate efficient target RNA cleavage in the lysate, and the cleavage site is located near the center of the region spanned by the guiding siRNA. Furthermore, we provide evidence that the direction of dsRNA processing determines whether sense or antisense target RNA can be cleaved by the produced siRNP complex.

Claims (31)

1. A method for preparing a double stranded RNA molecule which mediates the cleavage of an mRNA in a mammalian cell, comprising

(a) synthesizing two RNA strands each having a length from 19–25 nucleotides, and

(b) combining the synthesized RNA strands under conditions suitable to form a double stranded RNA molecule, wherein said double stranded RNA molecule has a double stranded region of 14–24 nucleotides in length and one or two 3′ overhang regions of 1–5 nucleotides in length.

2. The method according to claim 1 , wherein said RNA strands have a length of 21–24 nucleotides in length.

3. The method according to claim 2 , wherein said overhang regions are 2–4 nucleotides in length.

4. The method according to claim 1 , wherein the RNA strands are chemically synthesized.

5. The method according to claim 1 , wherein the RNA strands are enzymatically synthesized.

6. A method for preparing a double stranded RNA molecule which mediates the cleavage of a target mRNA in a mammalian cell, comprising

(a) selecting a target mammalian mRNA sequence or target gene sequence,

(b) synthesizing a first RNA strand having a length from 19–25 nucleotides, wherein said first RNA strand is complementary to contiguous nucleotides in said target mammalian mRNA or said target gene sequence

(c) synthesizing a second RNA strand having a length from 19–25 nucleotides, wherein said second RNA strand is complementary to 14–24 nucleotides from said first RNA strand, and

(d) combining the first and second RNA strands under conditions suitable to form a double stranded RNA molecule, wherein said double stranded RNA molecule has a double stranded region of 14–24 nucleotides in length and one or two 3′ overhang regions of 1–5 nucleotides in length.

7. An improved method for preparing a double stranded RNA molecule for mediating the cleavage of an mRNA in a mammalian cell, comprising synthesizing a double stranded RNA molecule,

wherein the improvement comprises synthesizing a double stranded RNA molecule having a double stranded region of 16–24 nucleotides in length and one or more 3′ overhang regions of 1–3 nucleotides in length.

8. An improved method for preparing a double stranded RNA molecule for mediating the cleavage of an mRNA in a mammalian cell, comprising preparing and isolating a double stranded RNA molecule,

wherein the improvement comprises preparing and isolating a double stranded RNA molecule having a double stranded region of 16–24 nucleotides in length and one or more 3′ overhang regions of 1–3 nucleotides in length.

9. A method for preparing a double stranded RNA molecule which mediates the cleavage of an mRNA in a mammalian cell, comprising

(a) synthesizing two RNA strands each having a length from 19–23 nucleotides, and

(b) combining the synthesized RNA strands under conditions suitable to form a double stranded RNA molecule, wherein said double stranded RNA molecule has a double stranded region of 14–22 nucleotides in length and one or two 3′ overhang regions of 1–5 nucleotides in length.

10. The method according to claim 9 , wherein said overhang regions are 2–4 nucleotides in length.

11. The method according to claim 9 , wherein the RNA strands are chemically synthesized.

12. The method according to claim 9 , wherein the RNA strands are enzymatically synthesized.

13. A method for preparing a double stranded RNA molecule which mediates the cleavage of a target mRNA in a mammalian cell, comprising

(a) selecting a target mammalian mRNA sequence or target gene sequence,

(b) synthesizing a first RNA strand having a length from 19–23 nucleotides, wherein said first RNA strand is complementary to contiguous nucleotides in said target mammalian mRNA or said target gene sequence

(c) synthesizing a second RNA strand having a length from 19–23 nucleotides, wherein said second RNA strand is complementary to 16–22 nucleotides from said first RNA strand, and

(d) combining the first and second RNA strands under conditions suitable to form a double stranded RNA molecule, wherein said double stranded RNA molecule has a double stranded region of 16–22 nucleotides in length and one or two 3′ overhang regions of 1–5 nucleotides in length.

14. An improved method for preparing a double stranded RNA molecule for mediating the cleavage of an mRNA in a mammalian cell, comprising synthesizing a double stranded RNA molecule,

wherein the improvement comprises synthesizing a double stranded RNA molecule having a double stranded region of 16–22 nucleotides in length and one or more 3′ overhang regions of 1–3 nucleotides in length.

15. An improved method for preparing a double stranded RNA molecule for mediating the cleavage of an mRNA in a mammalian cell, comprising preparing and isolating a double stranded RNA molecule,

wherein the improvement comprises preparing and isolating a double stranded RNA molecule having a double stranded region of 16–22 nucleotides in length and one or more 3′ overhang regions of 1–3 nucleotides in length.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE OMISSION OF ASSIGNEE, MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V., PREVIOUSLY RECORDED ON REEL 026583 FRAME 0614. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jul 20, 2011
From: MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY; WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH; UNIVERSITY OF MASSACHUSETTS; MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.
Reel/Frame 026622/0057 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2011
From: MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY; WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH; UNIVERSITY OF MASSACHUSETTS
Reel/Frame 026583/0614 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2009
From: EUROPAEISCHES LABORATORIUM FUER MOLEKULARBIOLOGIE (EMBL)
To: MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.
Reel/Frame 023486/0572 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2009
From: ELBASHIR, SAYDA; LENDECKEL, WINFRIED
To: MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN. E.V.
Reel/Frame 022240/0958 →
Priority Claims (1)
EP 00126325 · Dec 1, 2000 · regional
Continuity (3)
Division 1043305000
Provisional Application 6027966100 · Mar 30, 2001
Related Publication 20040259248A1 · Dec 23, 2004